NeuroControl Vocare bladder/bowel control implant trials to begin in coming weeks.
This article was originally published in The Gray Sheet
Executive Summary
NEUROCONTROL VOCARE BLADDER/BOWEL CONTROL IMPLANT PATIENT ENROLLMENT in U.S. clinicals is expected to begin in the next several weeks pending institutional review board approval at the clinical study sites, the company says. IRB submissions for The Vocare Bladder System, which is designed to restore bladder and bowel function in patients with injured spinal cords, are pending at five U.S. centers in the U.S. NeuroControl Corp. is hoping that study implants will begin in June after baseline data is gathered for enrolled patients.